Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation
Status:
Terminated
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
This study is designed to see if the use of the drug Sitagliptin (used to reduce insulin
resistance) will delay or prevent kidney transplant patients from getting diabetes.